日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Targeting Overexpressed IDO in Stromal Cells as a Potential Therapeutic Strategy in Multiple Myeloma

靶向基质细胞中过度表达的IDO作为多发性骨髓瘤的潜在治疗策略

期刊:Cancer Science
影响因子:4.5
doi:10.1111/cas.70255.
Toru Ebina,Masaki Ri,Yoshiaki Marumo,Tomoyuki Nakamura,Hirokazu Sasaki,Yoshiko Oshima,Takahiro Nakashima,Shinya Hagiwara,Arisa Asano,Shiori Kinoshita,Tomotaka Suzuki,Tomoko Narita,Ayako Masaki,Takaomi Sanda,Kazufumi Yamagata,Kohmei Kubo,Hirokazu Komatsu,Hirotake Sakuraba,Shinsuke Iida
骨髓瘤
细胞生物学
基质细胞
IDO
发表日期：2026
文献求助 收藏

Inhibiting KRAS with CD47 and immune checkpoint overcomes intrinsic resistance to combined KRAS and immune checkpoint inhibitor therapy

利用 CD47 和免疫检查点抑制剂抑制 KRAS 可克服对 KRAS 和免疫检查点抑制剂联合疗法的内在耐药性。

期刊:Cell Reports Medicine
影响因子:11.7
doi:10.1016/j.xcrm.2025.102317
Kentaro Hirade,Noritaka Tanaka,Taisuke Kajino,Yuta Adachi,Ryo Kimura,Hitomi Kasuya,Satoru Kisoda,Tze King Tan,Sho Hayakawa,Takahiko Sato,Shogo Yanase,Yoko Kitaura,Takamasa Yamamoto,Yuki Nishioka,Osamu Muto,Daisuke Muraoka,Teruaki Fujishita,Natsumi Kasuga,Kageaki Watanabe,Yoshihiko Sakata,Masahiro Aoki,Hirokazu Matsushita,Takaomi Sanda,Shinsuke Iida,Kohsuke Tsuchiya,Rui Yamaguchi,Hiromichi Ebi
免疫/内分泌
CD4
CD47
RAS
Checkpoint
发表日期：2025
文献求助 收藏

Phase I study on neoadjuvant combination immunotherapy with mogamulizumab and nivolumab for solid tumors

针对实体瘤的新辅助联合免疫疗法（mogamulizumab 和 nivolumab）的 I 期研究

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.3
doi:10.1136/jitc-2024-010634.
Koichi Jinushi #,Takuro Saito #,Koji Kurose,Susumu Suzuki,Takashi Kojima,Taishi Takahara,Tomoki Makino,Tetsuya Ogawa,Hiroyoshi Nishikawa,Kazuhiro Kakimi,Shinsuke Iida,Jun Nakajima,Yuichiro Doki,Mikio Oka,Ryuzo Ueda,Hisashi Wada
免疫/内分泌
MOG
发表日期：2025
文献求助 收藏

A novel T cell-redirecting anti-GPRC5D × CD3 bispecific antibody with potent antitumor activity in multiple myeloma preclinical models

一种新型 T 细胞重定向抗 GPRC5D × CD3 双特异性抗体，在多发性骨髓瘤临床前模型中具有强效抗肿瘤活性

期刊:Scientific Reports
影响因子:3.8
doi:10.1038/s41598-024-55143-0
Urara Tomita #, Yoko Ishimoto #, Masaki Ri #, Yumi Kawase, Yoshiyuki Hizukuri, Chikako Maru, Kayoko Nanai, Ryuichi Nakamura, Makiko Nakayama, Keiko Oguchi-Oshima, Hiroyuki Sumi, Toshiaki Ohtsuka, Shinsuke Iida, Toshinori Agatsuma
肿瘤
骨髓瘤
T细胞
发表日期：2024
文献求助 收藏

Integrated analysis of phase 1a and 1b randomized controlled trials; Treg-targeted cancer immunotherapy with the humanized anti-CCR4 antibody, KW-0761, for advanced solid tumors

对 1a 期和 1b 期随机对照试验进行综合分析；使用人源化抗 CCR4 抗体 KW-0761 进行 Treg 靶向癌症免疫疗法治疗晚期实体瘤

期刊:PLoS One
影响因子:2.9
doi:10.1371/journal.pone.0291772.
Kaoru Fujikawa,Takuro Saito,Koji Kurose,Takashi Kojima,Takeru Funakoshi,Eiichi Sato,Kazuhiro Kakimi,Shinsuke Iida,Yuichiro Doki,Mikio Oka,Ryuzo Ueda,Hisashi Wada
Human
肿瘤
免疫/内分泌
T细胞
T细胞
发表日期：2023
文献求助 收藏

Metastatic renal cell carcinoma of the lumbar spine with long posterior instrumented fusion and repetitive dislodgement of the set screws of the S2 alar-iliac screw

腰椎转移性肾细胞癌伴长节段后路内固定融合术，以及S2翼髂螺钉固定螺钉反复脱位。

期刊:
影响因子:
doi:10.25259/SNI_859_2023
Yoshida, Shinsuke; Iida, Shunpei; Akagawa, Rei; Oya, Soichi; Saita, Kazuo; Ogihara, Satoshi
肿瘤
肾癌
肿瘤免疫
细胞生物学
发表日期：2023
文献求助 收藏

IRF4 drives clonal evolution and lineage choice in a zebrafish model of T-cell lymphoma

IRF4 在斑马鱼 T 细胞淋巴瘤模型中驱动克隆进化和谱系选择

期刊:Nature Communications
影响因子:14.7
doi:10.1038/s41467-022-30053-9
Stella Amanda #, Tze King Tan #, Jolynn Zu Lin Ong, Madelaine Skolastika Theardy, Regina Wan Ju Wong, Xiao Zi Huang, Muhammad Zulfaqar Ali, Yan Li, Zhiyuan Gong, Hiroshi Inagaki, Ee Yong Foo, Brendan Pang, Soo Yong Tan, Shinsuke Iida, Takaomi Sanda
免疫
细胞生物学
肿瘤
淋巴瘤
T细胞
发表日期：2022
文献求助 收藏

CCR7 alterations associated with inferior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatment

CCR7 变异与接受 Mogamulizumab 治疗的成人 T 细胞白血病/淋巴瘤疗效较差相关

期刊:Hematological Oncology
影响因子:3.3
doi:10.1002/hon.3072
Yuma Sakamoto, Takashi Ishida, Ayako Masaki, Takayuki Murase, Eiichi Ohtsuka, Morishige Takeshita, Reiji Muto, Hiromi Iwasaki, Asahi Ito, Shigeru Kusumoto, Nobuaki Nakano, Masahito Tokunaga, Kentaro Yonekura, Yukie Tashiro, Shinsuke Iida, Atae Utsunomiya, Ryuzo Ueda, Hiroshi Inagaki
肿瘤
淋巴瘤
白血病
T细胞
发表日期：2022
文献求助 收藏

Depletion of central memory CD8+ T cells might impede the antitumor therapeutic effect of Mogamulizumab

中央记忆CD8+ T细胞的耗竭可能会阻碍莫加莫珠单抗的抗肿瘤治疗效果

期刊:Nature Communications
影响因子:14.7
doi:10.1038/s41467-021-27574-0
Yuka Maeda #,Hisashi Wada #,Daisuke Sugiyama #,Takuro Saito,Takuma Irie,Kota Itahashi,Kodai Minoura,Susumu Suzuki,Takashi Kojima,Kazuhiro Kakimi,Jun Nakajima,Takeru Funakoshi,Shinsuke Iida,Mikio Oka,Teppei Shimamura,Toshihiko Doi,Yuichiro Doki,Eiichi Nakayama,Ryuzo Ueda,Hiroyoshi Nishikawa
细胞生物学
肿瘤
T细胞
CD8
T细胞
发表日期：2021
文献求助 收藏

Small-molecule HDAC and Akt inhibitors suppress tumor growth and enhance immunotherapy in multiple myeloma

小分子HDAC和Akt抑制剂可抑制肿瘤生长并增强多发性骨髓瘤的免疫治疗效果

期刊:Journal of Experimental & Clinical Cancer Research
影响因子:11.4
doi:10.1186/s13046-021-01909-7
Mitsuhito Hirano ，Yoichi Imai ，Yuta Kaito ，Takahiko Murayama ，Kota Sato ，Tadao Ishida ，Junichi Yamamoto ，Takumi Ito ，Muneyoshi Futami ，Masaki Ri ，Hiroshi Yasui ，Tamami Denda ，Yukihisa Tanaka ，Yasunori Ota ，Masanori Nojima ，Yasuhiko Kamikubo ，Noriko Gotoh ，Shinsuke Iida ，Hiroshi Handa ，Arinobu Tojo
骨髓瘤
肿瘤
免疫/内分泌
肿瘤免疫
多发性骨髓瘤
发表日期：2021
文献求助 收藏